Company: NCEL
Filing Date: 2025-02-10
Form Type: F-3
Source: 0001213900-25-011823
Chunk: 119

Company: NewcelX Ltd.
Filing Date: 2025-02-10
Form: F-3
Chunk 119
---
 preferred shares.

The Company’s preferred shares have been granted
to their holders with a right to convert such preferred shares into common shares, certain limitations on conversion subject to beneficial
ownership limitations as well as a full ratchet adjustment provision in the event the Company issues securities at a price per share less
than the conversion price then in effect of the preferred shares.

Preferred Participation Certificates

As of the date hereof, 606,452 preferred participation
certificates are issued and outstanding, consisting of 125,000 of such PPCs are held in treasury and the remaining balance of 481,452
are held by certain holders. PPCs provide holders with the rights of preferred shares, except PPCs have no voting rights.

<div align='center'>80

DESCRIPTION OF WARRANTS</div>

The Company has issued 806,452
common warrants under a Securities Purchase Agreement between the Company and certain accredited investors dated October 9, 2024. These
common warrants entitle to purchase 806,452 Common Shares at an exercise price of USD $3.10 and a term of five years from October 11,
2024. The Company currently has 756,452 common warrants outstanding under such Securities Purchase Agreement as of February 7, 2025.

The Company has issued and has
outstanding 109,801 warrants under an Amendment to the Common Shares Purchase Warrants between the Company and certain accredited investors
dated October 9, 2024. These warrants entitle to purchase 136,523 Common Shares at an exercise price of CHF 0.80 and a term of ten (10)
years from October 9, 2024.

On June 28, 2024, the Company
entered into a securities purchase agreement for the issuance of 81,944 Common Shares at a purchase price of $9.60 per
share. The offering closed on July 1, 2024. Investors also received unregistered warrants to purchase up to 81,944 Common Shares
at an exercise price of $9.60 per share. These warrants are exercisable upon issuance and will expire five years from the
date of issuance.

H.C. Wainwright & Co., LLC
served as the exclusive placement agent for the offering. The Company issued to H.C. Wainwright & Co., LLC warrants to purchase up
to 5,736 Common Shares at an exercise price of $12.00 per share. These warrants are exercisable from the date of issuance
until